Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT03063619 M.D. Anderson Cancer Center Recruiting
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II... Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery NCT02598557 National Cancer Institute (NCI) Active, not recruiting
Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers Aspirin, Laboratory Biomarker Analysis, Placebo, Zileuton NCT02348203 National Cancer Institute (NCI) Active, not recruiting
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful... Aspirin, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT02521285 National Cancer Institute (NCI) Active, not recruiting
Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission Berberine Chloride, Laboratory Biomarker Analysis, Placebo NCT02365480 National Cancer Institute (NCI) Active, not recruiting
Broccoli Sprout/Broccoli Seed Extract Supplement in Decreasing Toxicity in Heavy Smokers Broccoli Sprout/Broccoli Seed Extract Supplement, Laboratory Biomarker Analysis, Questionnaire Administration NCT03402230 National Cancer Institute (NCI) Active, not recruiting
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric... Curcumin, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Placebo Administration NCT02782949 National Cancer Institute (NCI) Recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection DNA Plasmid Encoding Interleukin-12 INO-9012, Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment NCT02772003 National Cancer Institute (NCI) Active, not recruiting
Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers Laboratory Biomarker Analysis, Placebo, Questionnaire Administration, Dolcanatide NCT03300570 National Cancer Institute (NCI) Active, not recruiting
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment NCT02273362 National Cancer Institute (NCI) Active, not recruiting

Pages